Skip to main content
U.S. flag

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock (  ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Find more clinical trials

CADASIL Registry

Start: June 3, 2022
End: October 2027
Enrollment: 2500

What Is This Study About?

CADASIL, or cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, is a rare genetic disorder affecting the small blood vessels in the brain. The CADASIL Registry is enrolling people who have or are at risk of developing CADASIL, or who have a family member or other loved one with CADASIL. After joining the CADASIL Registry, volunteers will be invited to participate in studies on CADASIL.

Do I Qualify To Participate in This Study?

Minimum Age: 18 Years

Maximum Age: 90 Years

Must have:

  • Person with CADASIL or at risk for CADASIL, or have a loved one or a family member with CADASIL

Must NOT have:

  • None

If I Qualify, Who Do I Contact?

Contact study personnel listed either under the general study contact or the location nearest you.

 
Study Contact
CADASIL Consortium

Need Help?

Contact NIA’s Alzheimer’s and related Dementias Education and Referral (ADEAR) Center at 800-438-4380 or email ADEAR.

Where Is This Study Located?

Wisconsin
University of Wisconsin
Madison, WI 53705
Recruiting
CADASIL Consortium

Who Sponsors This Study?

Lead: University of Wisconsin-Madison

Source: ClinicalTrials.gov ID: NCT05567744

 

alzheimers.gov

An official website of the U.S. government, managed by the National Institute on Aging at the National Institutes of Health